Table 3 Haematological adverse events

From: A phase II study of capecitabine and docetaxel combination chemotherapy in patients with advanced gastric cancer

 

Grade (% of patients)

 

1

2

3

4

Anaemia

40

22

7

0

Leukopenia

29

36

10

2

Neutropenia

36

24

5

10

Thrombocytopenia

10

12

7

0

Back to article page